FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hikma's galantamine hydrobromide, authorizing its marketing as a generic product for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)

Snippet

SUPPL AP for GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)